A TAP2 genotype associated with Alzheimer's disease in APOE4 carriers

Neurobiology of Aging

Volumn 28, Issue 4, 2007, Pages 519-523

  Bullido, María J ^a   Martínez García, Ana ^a   Artiga, María J ^a   Aldudo, Jesús ^a   Sastre, Isabel ^a   Gil, Pedro ^b   Coria, Francisco ^c   Muñoz, David G ^d   Hachinski, Vladimir ^d   Frank, Ana ^a   Valdivieso, Fernando ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c St Michael's Hospital ^*

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Alzheimer's disease; APOE; Genetic risk factor; Interaction; TAP

Indexed keywords

APOLIPOPROTEIN E4; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 2; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HERPES SIMPLEX VIRUS 1; HETEROZYGOTE; HUMAN; IMMUNOSURVEILLANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BINDING; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; ATP-BINDING CASSETTE TRANSPORTERS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC;

EID: 33847101946     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2006.02.011     Document Type: Article

References (17)

1. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 18 4 Suppl (1997) S1-S2
2. Bauer D., and Tampe R. Herpes viral proteins blocking the transporter associated with antigen processing TAP-from genes to function and structure. Curr Top Microbiol Immunol 269 (2002) 87-99
3. Bertram L., and Tanzi R.E. Alzheimer's disease: one disorder, too many genes?. Hum Mol Genet 13 Spec 1 (2004) R135-R141
4. Bertram L., and Tanzi R.E. The genetic epidemiology of neurodegenerative disease. J Clin Invest 115 6 (2005) 1449-1457
5. Bullido M.J., Artiga M.J., Recuero M., Sastre I., Garcia M.A., Aldudo J., et al. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat Genet 18 1 (1998) 69-71
6. Burgos J.S., Ramirez C., Sastre I., Bullido M.J., and Valdivieso F. Involvement of apolipoprotein E in the hematogenous route of herpes simplex virus type 1 to the central nervous system. J Virol 76 23 (2002) 12394-12398
7. Burgos J.S., Ramirez C., Sastre I., Bullido M.J., and Valdivieso F. apoE4 is more efficient than E3 in brain access by herpes simplex virus type 1. Neuroreport 14 14 (2003) 1825-1827
8. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 5123 (1993) 921-923
9. Daniel S., Caillat-Zucman S., Hammer J., Bach J.F., and van Endert P.M. Absence of functional relevance of human transporter associated with antigen processing polymorphism for peptide selection. J Immunol 159 5 (1997) 2350-2357
10. Djilali-Saiah I., Benini V., Daniel S., Assan R., Bach J.F., and Caillat-Zucman S. Linkage disequilibrium between HLA class II (DR, DQ, DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex. Tissue Antigens 48 2 (1996) 87-92
11. Fratiglioni L., De Ronchi D., and Aguero-Torres H. Worldwide prevalence and incidence of dementia. Drugs Aging 15 5 (1999) 365-375
12. Itzhaki R.F., Dobson C.B., Shipley S.J., and Wozniak M.A. The role of viruses and of APOE in dementia. Ann NY Acad Sci 1019 (2004) 15-18
13. Lambert J.C., Goumidi L., Vrieze F.W., Frigard B., Harris J.M., Cummings A., et al. The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease. Hum Mol Genet 9 15 (2000) 2275-2280
14. Laws S.M., Hone E., Gandy S., and Martins R.N. Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J Neurochem 84 6 (2003) 1215-1236
15. McCluskey J., Rossjohn J., and Purcell A.W. TAP genes and immunity. Curr Opin Immunol 16 5 (2004) 651-659
16. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 7 (1984) 939-944
17. Wilson H.S., and Skodol A. Special report: DSM-IV: overview and examination of major changes. Arch Psychiatr Nurs 8 6 (1994) 340-347